Yu Zhang

Yu Zhang

Vertex Pharmaceuticals - Boston / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1680121
-
person_outline Yu Zhang's MOST POPULAR ARTICLES
1-) Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editingC Long, H Li, M Tiburcy, C Rodriguez-Caycedo, V Kyrychenko, H Zhou, ...Science advances 4 (1), eaap9004, 20182502018
2-) CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and miceY Zhang, C Long, H Li, JR McAnally, KK Baskin, JM Shelton, ...Science advances 3 (4), e1602814, 20172372017
3-) Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery systemY Zhang, H Li, YL Min, E Sanchez-Ortiz, J Huang, AA Mireault, JM Shelton, ...Science advances 6 (8), eaay6812, 20201432020
4-) A New Immuno-, Dystrophin-Deficient Model, the NSG-mdx4Cv Mouse, Provides Evidence for Functional Improvement Following Allogeneic Satellite Cell …RW Arpke, R Darabi, TL Mader, Y Zhang, A Toyama, C Lonetree, N Nash, ...Stem cells 31 (8), 1611-1620, 20131132013
5-) Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized miceAC Chai, M Cui, F Chemello, H Li, K Chen, W Tan, A Atmanli, ...Nature medicine 29 (2), 401-411, 2023802023